Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Immunogen affinity purified
Reconstitute at 0.2 mg/mL in sterile PBS.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for NgR2/NgRH1/RTN4RL2 Antibody [Unconjugated]
reticulon 4 receptor-like 2
NgR2, also known as reticulon 4 receptor-like 2 and NgR2, is a 60 kDa
glycosylphosphatidylinositol-anchored protein that is expressed
primarily in the brain. It contains eight leucine-rich repeats that are
flanked by cysteine-rich sequences at both the N- as well as the
C-terminus. Membrane-anchored NgR2 can be solubilized through the
action of phospholipase or an unidentified MT-MMP to generate a 46 kDa
soluble receptor. Mature human NgR2 shares 48% aa sequence identity
with human NgRH2. It also shares 96% aa sequence identity with mouse
and rat mature NgR2.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our NgR2/NgRH1/RTN4RL2 Antibody [Unconjugated] and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.